News & Updates
Filter by Specialty:
Maternal levothyroxine exposure not associated with neurodevelopmental disorders in offspring
Levothyroxine exposure during pregnancy is not associated with an increased risk of attention-deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) in the offspring, a territory-wide retrospective cohort study in Hong Kong has shown.
Maternal levothyroxine exposure not associated with neurodevelopmental disorders in offspring
02 Dec 2022
Total ankle replacement vs arthrodesis: Which is better for ankle osteoarthritis?
Total ankle replacement (TAR) and ankle fusion (AF) or arthrodesis both improve the Manchester–Oxford Foot Questionnaire walking/standing (MOXFQ-W/S) domain scores in patients with end-stage ankle osteoarthritis at 52 weeks after surgery, reports a study. The two surgical treatments also show similar clinical scores and number of harms.
Total ankle replacement vs arthrodesis: Which is better for ankle osteoarthritis?
01 Dec 2022
3-month rivaroxaban use safe, effective in isolated DVT
Treatment with rivaroxaban for 3 months leads to a safe and successful reduction of recurrent venous thromboembolism (VTE) risk compared to treatment for 6 weeks in patients with isolated distal deep vein thrombosis (DVT), a study has shown.
3-month rivaroxaban use safe, effective in isolated DVT
01 Dec 2022
1-year isometric exercise training improves BP management
Isometric exercise training (IET) appears to be a good long-term intervention in managing resting blood pressure (BP), reports a recent study. IET delivers clinically important, chronic BP adaptations in patients at risk of hypertension.
1-year isometric exercise training improves BP management
01 Dec 2022
Chinese herbal med cuts MACCE in STEMI, but questions remain
Tongxinluo, added to guideline-directed therapy, improves outcomes in patients with acute ST-segment elevation myocardial infarction (STEMI) in the large, multicentre CTS-AMI* study. But experts are clamouring for more evidence of efficacy.